GHK-Cu vs BPC-157

Overview

This comparison separates GHK-Cu and BPC-157 for reference—not product selection.

GHK-Cu: Naturally occurring copper-binding tripeptide, the most studied peptide in skin and collagen research.

BPC-157: Synthetic gastric peptide widely studied in animal tissue-repair models, with very limited human data.

Differences

• Both appear in Tissue repair & recovery research literature, but mechanistic framing differs.
• The useful distinction is research question and receptor context—not relative potency or practical ranking.

Mechanism

GHK-Cu: Copper is a required cofactor for lysyl oxidase, the enzyme that cross-links collagen and elastin into a stable structure. GHK acts as a carrier that delivers c…

BPC-157: The mechanism most consistently reported is an effect on new blood vessel formation, called angiogenesis. Healing tissue needs a blood supply, and BPC-157 appea…

Pharmacology

GHK-Cu: Pharmacokinetic detail should be read from primary literature.

BPC-157: Pharmacokinetic detail should be read from primary literature.

Research

GHK-Cu: Skin & dermatology research: Increases type I and III collagen production by up to 70% in human dermal fibroblasts.

BPC-157: Tissue repair & recovery research: Accelerated tendon-to-bone healing with improved biomechanical properties; most effective with localized injection.

Summary

Distinction

• AXIOM does not provide dosing, administration, or protocol guidance.
• Catalogue links appear only where AXIOM lists a research-use product.
• Reference-only compounds remain comparison terms without implying availability.

References

• pubmed.ncbi.nlm.nih.gov/29986520/
• pubmed.ncbi.nlm.nih.gov/39963574/
• pubmed.ncbi.nlm.nih.gov/38387323/
• pubmed.ncbi.nlm.nih.gov/26236730/
• pubmed.ncbi.nlm.nih.gov/22666519/
• pubmed.ncbi.nlm.nih.gov/39325560/
• pubmed.ncbi.nlm.nih.gov/32334036/
• pubmed.ncbi.nlm.nih.gov/40131143/

Questions